ImmunoChemistry Technologies (ICT) is excited to announce that we are now a part of the Janel Life Sciences Group of companies! Janel Life Sciences Group includes Antibodies Incorporated, Aves Labs, and PhosphoSolutions. Together, we offer customers a wide range of complementary products and services to advance life sciences research and diagnostics.
ICT was founded in 1994 as a biotech-services company focused on immunoassay development. We began with a catalog of immunoassay reagents and later added novel fluorescent cell viability assays to our catalog. Today, we are well-known in the biotech industry and proudly serve a diverse customer base including pharma, diagnostic, and academic scientists. ICT products are used worldwide by researchers to probe mechanisms of cell death, perform immunoassays, and to advance scientific understanding.
Antibodies Incorporated has supported scientific discovery since 1962 with an extensive catalog of widely-cited and validated neuroscience antibodies, including the well-known NeuroMab family of products. Antibodies Incorporated is also a leading provider of biotechnology services, offering custom antibody services and contract manufacturing of reagents and in vitro diagnostics at its ISO-13485 certified facility in Davis, CA.
Aves Labs, founded in 1995, is the world’s leading provider of chicken antibody products and services. Since inception, Aves Labs has developed novel antibody reagents against neural-specific antigens and epitope tags to foster scientific progress in neuroscience and the cell biology communities. Aves Labs also offers research and diagnostic customers access to their chicken antibody expertise via a wide range of custom services.
PhosphoSolutions (Aurora, CO), was founded in 2001 by Drs. Michael D. Browning, John W. Haycock, and Andrew J. Czernik who all worked together in the laboratory of Dr. Paul Greengard, co-recipient of the 2000 Nobel Prize in Medicine for his work on the role of protein phosphorylation in signal transduction in the nervous system. This expertise led to the development of a portfolio of over 300 antibodies — including 125 phospho-specific antibodies — focused primarily in the neuroscience field. PhosphoSolutions also offers their expertise in phospho-specific antibody development to researchers through their custom services.
ICT President Sally Ann Hed Dahlquist said, “I am thrilled about joining the Janel Life Sciences group of companies. ICT’s mission has always been to provide superior products and technical service to our customers. By joining this stellar group of like-minded companies, we now have the opportunity to reach more customers and also offer our customers a wider variety of life sciences products and services. I’m very excited for the future.”